NYSE:CI - US1255231003 - Common Stock
The current stock price of CI is 300.87 USD. In the past month the price increased by 14.74%. In the past year, price decreased by -16.84%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.66 | 15.08B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
DVA | DAVITA INC | 14.22 | 9.85B | ||
HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
CHE | CHEMED CORP | 20.47 | 6.67B | ||
RDNT | RADNET INC | 199.33 | 5.52B | ||
OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B | ||
CRVL | CORVEL CORP | 46.14 | 4.57B |
The Cigna Group is a global health company, which engages in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 73,500 full-time employees. The firm has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
THE CIGNA GROUP
900 Cottage Grove Road
Bloomfield CONNECTICUT 06002 US
CEO: David M. Cordani
Employees: 73500
Phone: 18602266000
The current stock price of CI is 300.87 USD. The price increased by 0.63% in the last trading session.
The exchange symbol of THE CIGNA GROUP is CI and it is listed on the New York Stock Exchange, Inc. exchange.
CI stock is listed on the New York Stock Exchange, Inc. exchange.
34 analysts have analysed CI and the average price target is 367.43 USD. This implies a price increase of 22.12% is expected in the next year compared to the current price of 300.87. Check the THE CIGNA GROUP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
THE CIGNA GROUP (CI) has a market capitalization of 80.31B USD. This makes CI a Large Cap stock.
THE CIGNA GROUP (CI) currently has 73500 employees.
THE CIGNA GROUP (CI) has a support level at 300.55 and a resistance level at 318.85. Check the full technical report for a detailed analysis of CI support and resistance levels.
The Revenue of THE CIGNA GROUP (CI) is expected to grow by 9.21% in the next year. Check the estimates tab for more information on the CI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
THE CIGNA GROUP (CI) has a dividend yield of 2.02%. The yearly dividend amount is currently 5.53. Check the full fundamental report for a detailed analysis of CI dividend history, reliability and sustainability.
THE CIGNA GROUP (CI) will report earnings on 2025-10-29, before the market open.
The PE ratio for THE CIGNA GROUP (CI) is 10.71. This is based on the reported non-GAAP earnings per share of 28.09 and the current share price of 300.87 USD. Check the full fundamental report for a full analysis of the valuation metrics for CI.
The outstanding short interest for THE CIGNA GROUP (CI) is 0.93% of its float. Check the ownership tab for more information on the CI short interest.
ChartMill assigns a technical rating of 2 / 10 to CI. When comparing the yearly performance of all stocks, CI is a bad performer in the overall market: 84.54% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to CI. There are concerns on the financial health of CI while its profitability can be described as average.
Over the last trailing twelve months CI reported a non-GAAP Earnings per Share(EPS) of 28.09. The EPS increased by 5.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.92% | ||
ROA | 3.31% | ||
ROE | 12.48% | ||
Debt/Equity | 0.66 |
34 analysts have analysed CI and the average price target is 367.43 USD. This implies a price increase of 22.12% is expected in the next year compared to the current price of 300.87.
For the next year, analysts expect an EPS growth of 11.67% and a revenue growth 9.21% for CI